Q3 22: a record-breaking year ahead

24/11/22 -"Forecasts for a record year were not dented in Q3 22. AvH now boasts a strengthened liquidity position of €512m (vs. €213m in H1) driven by the Anima divestment. With a record order book for its ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

24/11/22

Download

You may also be interested by these reports :

25/11/25

ACKERMANS & VAN HAAREN

How Ackermans turns discipline into returns

25/11/25

Bolloré

We have taken into account the reverse split of Havas into our model, which was not previously properly accounted for, thereby unduly raising ...

24/11/25

Prosus

Growth is broad-based, margins are improving, and cash generation is finally part of the story. Tencent is back with earnings momentum, helped by ...

21/11/25

Ackermans & van Haaren

Ackermans & van Haaren delivered a solid Q3 25, extending the strong trajectory established in the first half of the year. The group reiterated its ...

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue